eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Journal's reviewers Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
5/2021
vol. 38
 
Share:
Share:
more
 
 
abstract:
Letter to the Editor

Rosacea fulminans with rhinophyma and severe eye complications in a young woman treated with isotretinoin

Joanna Pogorzelska-Dyrbuś
1
,
Marek Sosnowski
2
,
Jacek C. Szepietowski
3

1.
“Estevita” Specialist Medical Practice, Tychy, Poland
2.
Department of Ophthalmology, University Clinical Centre, Medical University of Silesia, Katowice, Poland
3.
Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland
Adv Dermatol Allergol 2021; XXXVIII (5): 903-905
Online publish date: 2020/04/25
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Rosacea is an inflammatory skin disease that affects the cheeks, nose, chin and forehead [1]. Rosacea fulminans is an extremely rare variant of rosacea, previously called pyoderma faciale, which usually occurs in healthy young women. It is characterised by an abrupt onset of erythematous papules, pustules, nodules and cysts on the background of – often severe – redness. The most worsened late stage of rosacea is called rhinophyma. The name, which was first used by Hebra in 1845, derives from the ancient Greek word “rhis”, which means nose, and “phyma”, meaning growth [2].
Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.